Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution shortage

To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-08-31 · last update 2026-08-31

Manufacturers: Fresenius Kabi USA, LLC

Stated reasons (per FDA): Not stated

Presentations

Presentation	Manufacturer	Status	Reason	Notes (FDA)	Dates
Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10)	Fresenius Kabi USA, LLC	To Be Discontinued	—	Discontinuation of the manufacture of the drug	Posted 08/31/2026 Updated 08/31/2026 Discontinued 08/31/2026